Literature DB >> 25848978

Molecular and Morphological Characterization of Inflammatory Infiltrate in Rosacea Reveals Activation of Th1/Th17 Pathways.

Timo Buhl1, Mathias Sulk2, Pawel Nowak3, Jörg Buddenkotte3, Ian McDonald4, Jérôme Aubert5, Isabelle Carlavan5, Sophie Déret5, Pascale Reiniche5, Michel Rivier5, Johannes J Voegel6, Martin Steinhoff7.   

Abstract

Rosacea is a common chronic inflammatory skin disease of unknown etiology. Our knowledge about an involvement of the adaptive immune system is very limited. We performed detailed transcriptome analysis, quantitative real-time reverse-transcriptase-PCR, and quantitative immunohistochemistry on facial biopsies of rosacea patients, classified according to their clinical subtype. As controls, we used samples from patients with facial lupus erythematosus and healthy controls. Our study shows significant activation of the immune system in all subtypes of rosacea, characterizing erythematotelangiectatic rosacea (ETR) already as a disease with significant influx of proinflammatory cells. The T-cell response is dominated by Th1/Th17-polarized immune cells, as demonstrated by significant upregulation of IFN-γ or IL-17, for example. Chemokine expression patterns support a Th1/Th17 polarization profile of the T-cell response. Macrophages and mast cells are increased in all three subtypes of rosacea, whereas neutrophils reach a maximum in papulopustular rosacea. Our studies also provide evidence for the activation of plasma cells with significant antibody production already in ETR, followed by a crescendo pattern toward phymatous rosacea. In sum, Th1/Th17 polarized inflammation and macrophage infiltration are an underestimated hallmark in all subtypes of rosacea. Therapies directly targeting the Th1/Th17 pathway are promising candidates in the future treatment of this skin disease.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25848978     DOI: 10.1038/jid.2015.141

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  59 in total

Review 1.  CD79: a review.

Authors:  P G Chu; D A Arber
Journal:  Appl Immunohistochem Mol Morphol       Date:  2001-06

Review 2.  Pax5: a master regulator of B cell development and leukemogenesis.

Authors:  Jasna Medvedovic; Anja Ebert; Hiromi Tagoh; Meinrad Busslinger
Journal:  Adv Immunol       Date:  2011       Impact factor: 3.543

Review 3.  Rosacea: classification and treatment.

Authors:  T Jansen; G Plewig
Journal:  J R Soc Med       Date:  1997-03       Impact factor: 5.344

Review 4.  Rosacea under the microscope: characteristic histological findings.

Authors:  B Cribier
Journal:  J Eur Acad Dermatol Venereol       Date:  2013-03-04       Impact factor: 6.166

5.  Positive correlation between serum immunoreactivity to Demodex-associated Bacillus proteins and erythematotelangiectatic rosacea.

Authors:  N O'Reilly; N Menezes; K Kavanagh
Journal:  Br J Dermatol       Date:  2012-09-25       Impact factor: 9.302

6.  T-cell subsets in acne rosacea lesions and the possible role of Demodex folliculorum.

Authors:  T Rufli; S A Büchner
Journal:  Dermatologica       Date:  1984

7.  Human T cells that are able to produce IL-17 express the chemokine receptor CCR6.

Authors:  Satya P Singh; Hongwei H Zhang; John F Foley; Michael N Hedrick; Joshua M Farber
Journal:  J Immunol       Date:  2008-01-01       Impact factor: 5.422

Review 8.  IL-22, not simply a Th17 cytokine.

Authors:  Sascha Rutz; Céline Eidenschenk; Wenjun Ouyang
Journal:  Immunol Rev       Date:  2013-03       Impact factor: 12.988

9.  Permethrin 5% cream versus metronidazole 0.75% gel for the treatment of papulopustular rosacea. A randomized double-blind placebo-controlled study.

Authors:  Mukadder Koçak; Salime Yağli; Güler Vahapoğlu; Meral Ekşioğlu
Journal:  Dermatology       Date:  2002       Impact factor: 5.366

10.  Reduction in serine protease activity correlates with improved rosacea severity in a small, randomized pilot study of a topical serine protease inhibitor.

Authors:  Aimee M Two; Tissa R Hata; Teruaki Nakatsuji; Alvin B Coda; Paul F Kotol; Wiggin Wu; Faiza Shafiq; Eugene Y Huang; Richard L Gallo
Journal:  J Invest Dermatol       Date:  2013-11-08       Impact factor: 8.551

View more
  37 in total

1.  Development of Papulopustular Rosacea during Nivolumab Therapy for Metastatic Cancer.

Authors:  Emilie Bousquet; Allison Zarbo; Emilie Tournier; Christine Chevreau; Julien Mazieres; Mario E Lacouture; Vincent Sibaud
Journal:  Acta Derm Venereol       Date:  2017-04-06       Impact factor: 4.437

2.  Development of Ocular Rosacea following Combined Ipilimumab and Nivolumab Treatment for Metastatic Malignant Skin Melanoma.

Authors:  Niels J Brouwer; John B A G Haanen; Martine J Jager
Journal:  Ocul Oncol Pathol       Date:  2017-02-02

3.  Assessment of the Development of New Regional Dermatoses in Patients Treated for Atopic Dermatitis With Dupilumab.

Authors:  Gefei Alex Zhu; Jennifer K Chen; Albert Chiou; Justin Ko; Golara Honari
Journal:  JAMA Dermatol       Date:  2019-07-01       Impact factor: 10.282

Review 4.  Cutaneous and ocular rosacea: Common and specific physiopathogenic mechanisms and study models.

Authors:  Daniela Rodrigues-Braz; Min Zhao; Nilufer Yesilirmak; Selim Aractingi; Francine Behar-Cohen; Jean-Louis Bourges
Journal:  Mol Vis       Date:  2021-05-13       Impact factor: 2.367

5.  Prevalence of rosacea in the general population of Germany and Russia - The RISE study.

Authors:  J Tan; H Schöfer; E Araviiskaia; F Audibert; N Kerrouche; M Berg
Journal:  J Eur Acad Dermatol Venereol       Date:  2016-03       Impact factor: 6.166

6.  Keratinocyte-Immune Cell Crosstalk in a STAT1-Mediated Pathway: Novel Insights Into Rosacea Pathogenesis.

Authors:  Zhili Deng; Fangfen Liu; Mengting Chen; Chuchu Huang; Wenqin Xiao; Sini Gao; Dan Jian; Yuyan Ouyang; San Xu; Jinmao Li; Qian Shi; Hongfu Xie; Guohong Zhang; Ji Li
Journal:  Front Immunol       Date:  2021-07-05       Impact factor: 7.561

Review 7.  Hallmarks of Aging in Macrophages: Consequences to Skin Inflammaging.

Authors:  Gabriela Rapozo Guimarães; Palloma Porto Almeida; Leandro de Oliveira Santos; Leane Perim Rodrigues; Juliana Lott de Carvalho; Mariana Boroni
Journal:  Cells       Date:  2021-05-26       Impact factor: 6.600

8.  Glucocorticoids promote CCL20 expression in keratinocytes.

Authors:  L Wang; M Yang; X Wang; B Cheng; Q Ju; D Z Eichenfield; B K Sun
Journal:  Br J Dermatol       Date:  2021-08-17       Impact factor: 11.113

9.  A Novel Mechanism of Carvedilol Efficacy for Rosacea Treatment: Toll-Like Receptor 2 Inhibition in Macrophages.

Authors:  Jiawen Zhang; Peiyu Jiang; Lei Sheng; Yunyi Liu; Yixuan Liu; Min Li; Meng Tao; Liang Hu; Xiaoyan Wang; Yanjing Yang; Yang Xu; Wentao Liu
Journal:  Front Immunol       Date:  2021-07-12       Impact factor: 7.561

10.  Association of COVID-19 with skin diseases and relevant biologics: a cross-sectional study using nationwide claim data in South Korea.

Authors:  S I Cho; Y E Kim; S J Jo
Journal:  Br J Dermatol       Date:  2020-10-13       Impact factor: 11.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.